Press Release
-
New Breakthrough: Japan & South Korea Patents Granted for Breast Cancer Treatment Response, Recurrence and Prognosis Monitoring
EG BioMed today announced a pivotal advancement in its global intellectual property portfolio. The company’s breakthrough technology for breast cancer monitoring has officially been granted patent certificates by the patent offices of Japan and South Korea, marking a significant achievement in EG BioMed’s ongoing commitment to delivering innovative diagnostic solutions to the international market. Advancing…
-
Taiwan EG BioMed Honored with the 22nd National Innovation Award – Enterprise Innovation Award
EG BioMed is proud to announce that we have been awarded the prestigious “Enterprise Innovation Award” at the 22nd National Innovation Awards. Our pioneering pancreatic cancer blood detection technology has once again earned major recognition for its breakthrough potential in the field of oncology. Pancreatic cancer is notoriously difficult to diagnose in its early stages…
-
EG BioMed US Inc. Earns International CAP Accreditation
We are proud to announce that EG BioMed’s Washington Laboratory has successfully passed the on-site inspection by the College of American Pathologists (CAP), earning official CAP accreditation — a globally recognized mark of laboratory excellence. Note 1：The College of American Pathologists (CAP) is the world’s largest organization of board-certified pathologists, focused on laboratory quality and…